ALLR
Price:
$1.16
Market Cap:
$16.85M
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 cli...[Read more]
Industry
Biotechnology
IPO Date
2021-12-21
Stock Exchange
NASDAQ
Ticker
ALLR
According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.33. This represents a change of -0.46% compared to the average of 2.34 of the last 4 quarters.
The mean historical Current Ratio of Allarity Therapeutics, Inc. over the last ten years is 1.48. The current 2.33 Current Ratio has changed 15.64% with respect to the historical average. Over the past ten years (40 quarters), ALLR's Current Ratio was at its highest in in the June 2016 quarter at 48.05. The Current Ratio was at its lowest in in the June 2018 quarter at 0.
Average
1.48
Median
0.74
Minimum
0.14
Maximum
5.68
Discovering the peaks and valleys of Allarity Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.86%
Maximum Annual Current Ratio = 5.68
Minimum Annual Increase = -76.47%
Minimum Annual Current Ratio = 0.14
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 2.06 | 1.38% |
| 2023 | 0.14 | -68.57% |
| 2022 | 0.44 | -56.43% |
| 2021 | 1.02 | 227.84% |
| 2020 | 0.31 | -56.25% |
| 2019 | 0.71 | 74.17% |
| 2018 | 0.41 | -47.09% |
| 2017 | 0.77 | -76.47% |
| 2016 | 3.27 | -42.44% |
| 2015 | 5.68 | 3.86% |
The current Current Ratio of Allarity Therapeutics, Inc. (ALLR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.88
5-year avg
0.79
10-year avg
1.48
Allarity Therapeutics, Inc.’s Current Ratio is greater than Cingulate Inc. (1.26), less than Processa Pharmaceuticals, Inc. (3.45), less than BriaCell Therapeutics Corp. (3.41), less than Lexaria Bioscience Corp. (3.90), less than Entero Therapeutics, Inc. (2.62), greater than Lixte Biotechnology Holdings, Inc. (1.84), less than Clearside Biomedical, Inc. (3.87), less than Kairos Pharma, Ltd. (16.56), greater than Curis, Inc. (0.70), greater than CASI Pharmaceuticals, Inc. (0.30),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.26 | $22.09M | |
| 3.45 | $15.36M | |
| 3.41 | $23.06M | |
| 3.90 | $20.27M | |
| 2.62 | $11.06M | |
| 1.84 | $19.34M | |
| 3.87 | $4.97M | |
| 16.56 | $18.86M | |
| 0.70 | $17.45M | |
| 0.30 | $15.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Allarity Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Allarity Therapeutics, Inc. (ALLR)?
What is the highest Current Ratio for Allarity Therapeutics, Inc. (ALLR)?
What is the 3-year average Current Ratio for Allarity Therapeutics, Inc. (ALLR)?
What is the 5-year average Current Ratio for Allarity Therapeutics, Inc. (ALLR)?
How does the current Current Ratio for Allarity Therapeutics, Inc. (ALLR) compare to its historical average?